This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...

The Atrial Fibrillation (AFib) market is currently undergoing substantial expansion, fueled by several converging factors ...

President and CEO Mike Carrel outlined the company’s strategy and growth outlook during a presentation and Q&A at a JPMorgan ...

Our Lady Of Lourdes Heart Hospital relocated its Electrophysiology Lab, expanding advanced AFib and heart rhythm care for ...

Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

While many people do feel symptoms—a rapid heartbeat, skipping a beat, dizziness, extreme shortness of breath—up to a third of those with AFib don’t realize they have it, either because they have no ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

In North Carolina, which had legislated its commitment to life, Ciji Graham spent her final days struggling to find anyone to save hers.

Key takeawaysAn international panel of more than 80 experts has issued updated guidance to improve care for atrial fibrillation (AF) patients ...

Cardiac Electrophysiology Institute Expands Catheter Ablation Access For Los Angeles Heart Rhythm Patients. <a href = target= ...

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is starting the new year with its first ...